Filing Flows › Acadia Pharmaceuticals (ACAD) › Q3 2026
Acadia Pharmaceuticals (ACAD) Q3 2026 earnings results (third quarter 2026)
10-Q filed Nov 5, 2026
Acadia Pharmaceuticals (ACAD) reported revenue of $342M for the third quarter 2026 (Q3 2026), +23% from a year earlier and +11% from the quarter before. Operating margin was 21.0%, net earnings $53.5M (15.6% of revenue).
Acadia Pharmaceuticals, Q3 2026: revenue $342M (+23% year over year), operating margin 21.0%, net earnings $53.5M, operating cash flow $11.5M. The chart follows the revenue to costs, profit and cash.
| Q3 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $342M | +11% | +23% |
| Operating profit | $71.7M | +90% | +101% |
| Net earnings | $53.5M | +70% | -25% |
| Operating cash flow | $11.5M | -89% | -85% |
| Free cash flow | $10.3M | -89% | -86% |
What changed
Revenue was $342.3M in Q3 2026, up 23% year over year and up 11% from the previous quarter. Nuplazid was the largest line at 59% of revenue. Daybue added $39.0M year over year (up 39%), 61% of the total change.
Operating profit was $71.7M, a 21.0% margin (up 8.1 points year over year). Of the extra revenue versus Q3 2025, 56% reached operating profit, above the 13% margin then. Total costs grew 11% against revenue growth of 23%. The fastest-growing cost line was Cost of revenue (+62%). Net earnings were $53.5M, down 25% year over year. The effective tax rate was 33.5%.
Operating cash flow was $11.5M (down 85% year over year), 21% of net earnings. Non-cash charges added back $3.7M of depreciation and amortization and $17.5M of share-based compensation. Working capital and other items used $63.1M. Capital expenditures of $1.2M left free cash flow of $10.3M.
Questions
What was Acadia Pharmaceuticals' revenue in the third quarter 2026?
Acadia Pharmaceuticals (ACAD) reported revenue of $342M for the third quarter 2026 (Q3 2026), +23% from a year earlier and +11% from the quarter before.
Was Acadia Pharmaceuticals profitable in the third quarter 2026?
Operating profit was $71.7M (21.0% of revenue) and net earnings $53.5M.